22nd Century Group Inc (XXII) Stock Rating Upgraded by Zacks Investment Research

22nd Century Group Inc (NYSE:XXII) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. The brokerage presently has a $1.25 target price on the biotechnology company’s stock. Zacks Investment Research’s price target indicates a potential downside of 10.07% from the stock’s previous close.

According to Zacks, “22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company’s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. “

Separately, Chardan Capital reiterated a “buy” rating and issued a $3.50 target price on shares of 22nd Century Group in a research report on Sunday, January 8th.

22nd Century Group (NYSE:XXII) traded up 3.73% during midday trading on Friday, reaching $1.39. 1,580,609 shares of the company were exchanged. The firm’s 50-day moving average is $1.12 and its 200-day moving average is $1.09. The firm’s market cap is $126.07 million. 22nd Century Group has a one year low of $0.73 and a one year high of $1.71.

TRADEMARK VIOLATION NOTICE: “22nd Century Group Inc (XXII) Stock Rating Upgraded by Zacks Investment Research” was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another site, it was illegally copied and republished in violation of United States & international copyright laws. The correct version of this article can be read at https://sportsperspectives.com/2017/04/21/22nd-century-group-inc-xxii-upgraded-to-buy-by-zacks-investment-research-updated-updated.html.

A hedge fund recently raised its stake in 22nd Century Group stock. National Asset Management Inc. boosted its stake in shares of 22nd Century Group Inc (NYSE:XXII) by 82.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,700 shares of the biotechnology company’s stock after buying an additional 66,000 shares during the period. National Asset Management Inc. owned about 0.16% of 22nd Century Group worth $197,000 as of its most recent filing with the SEC.

About 22nd Century Group

5 Day Chart for NYSE:XXII

Get a free copy of the Zacks research report on 22nd Century Group (XXII)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply